XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The fair value of each stock option granted during the nine months ended September 30, 2024 was estimated using the Black-Scholes assumptions and or factors as follows:

 

Exercise price  $0.84-$5.00 
Expected dividend yield   0%
Risk free interest rate   4.01%-4.25%
Expected life in years   10 
Expected volatility   213-215%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Stock Options               
Outstanding December 31, 2023   1,357,466   $7.39    4.39 
Granted   742,150    1.73    9.48 
Expired   (146,125)   5.85    - 
Exercised   -    -    - 
Outstanding September 30, 2024   1,953,491   $5.36    6.02 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of September 30, 2024, and changes during the nine months ended September 30, 2024 is presented below:

 

Nonvested Options  Options  

Weighted-Average

Exercise Price

 
Nonvested at December 31, 2023   49,832   $14.72 
Granted   742,150    1.73 
Vested   (164,412)   4.43 
Forfeited   -    - 
Nonvested at September 30, 2024   627,570   $2.06 
SUMMARY OF WARRANT

A summary of warrant issuances are as follows:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Warrants               
                
Outstanding December 31, 2023   942,566   $19.47    2.31 
Granted   -    -    - 
Expired   -    -    - 
Exercised   -    -    - 
Outstanding September 30, 2024   942,566   $19.47    1.56